Two Doses of BNT162b2 SARS-CoV-2 Vaccine Highly Effective
Real-world study shows vaccine effectiveness of 97.2 percent against COVID-19-related hospitalization, 96.7 percent against COVID-19-related death
Pfizer to Seek Approval in Fall for COVID-19 Vaccine Use in Children Aged 2...
Company also plans to apply to the FDA this month for full approval of the vaccine for use in people ages 16 to 85 years
Biden Administration to Back Lifting of COVID-19 Vaccine Patents
Global health activists note that patent holders must also share technical know-how and personnel
CDC Gives Cruise Ship Lines Guidelines for Simulated Voyages
Agency outlines how inspections of cruise ships will be conducted during simulated and restricted passenger voyages
Four-Month Rifapentine Regimen With Moxifloxacin Noninferior for TB
Rifapentine-based regimen with moxifloxacin noninferior to six-month control regimen of rifampin, isoniazid, pyrazinamide, ethambutol
HPV Vaccination Rates Low for Young Adults
Rates low for 18- to 21-year-olds reporting vaccination at any age or initiating in young adulthood
Efficacy of BNT162b2 mRNA COVID-19 Vaccine Lower in Patients With CLL
Second study shows lower neutralizing antibody titers against SARS-CoV-2 after the first dose among elderly patients with multiple myeloma
Vaccination, NPI Compliance Needed to Prevent COVID-19 Surges
Accelerated decline in nonpharmaceutical intervention adherence could undermine vaccine-related gains
COVID-19 Vaccine Hesitancy Found for 20 Percent on Hemodialysis
Increased odds of vaccine hesitancy seen for patients aged 18 to 44 years, Black and Native Americans or Pacific Islanders, women
Biden Sets New Goal of Vaccinating 70 Percent of Americans by July 4
So far, more than 56 percent of American adults have received at least one dose of a COVID-19 vaccine; more than 106 million fully vaccinated
